Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sygeplejebutikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.1% 4.1%   Bankruptcy risk   2.4% 1.6% 1.8% 1.0% 4.8% 1.7% 6.8% 6.6%   Credit score (0-100)   65 75 71 86 44 71 35 36   Credit rating   BBB A A A BBB A BBB BBB   Credit limit (kDKK)   0.0 2.6 1.1 223.4 0.0 2.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,506 1,590 10,732 0 0 0 0 0   Gross profit   1,506 1,590 2,029 3,569 1,982 3,381 0.0 0.0   EBITDA   512 477 764 1,443 -619 475 0.0 0.0   EBIT   462 430 679 1,377 -685 409 0.0 0.0   Pre-tax profit (PTP)   389.8 402.8 672.3 1,368.6 -768.1 291.5 0.0 0.0   Net earnings   296.2 314.0 520.2 1,040.4 -727.3 291.5 0.0 0.0   Pre-tax profit without non-rec. items   390 403 672 1,369 -768 291 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   29.4 22.0 84.5 58.5 32.4 6.4 0.0 0.0   Shareholders equity total   840 1,094 1,514 2,155 1,427 1,719 1,669 1,669   Interest-bearing liabilities   1,452 908 586 606 1,337 1,421 0.0 0.0   Balance sheet total (assets)   2,947 2,479 3,523 4,580 4,098 4,347 1,669 1,669   Net Debt   1,440 845 -175 43.6 1,293 1,363 -1,549 -1,549     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,506 1,590 10,732 0 0 0 0 0   Net sales growth   9.9% 5.6% 575.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,506 1,590 2,029 3,569 1,982 3,381 0.0 0.0   Gross profit growth   9.9% 5.6% 27.6% 75.9% -44.5% 70.6% -100.0% 0.0%   Employees   0 0 0 6 7 8 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 16.7% 14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,947 2,479 3,523 4,580 4,098 4,347 1,669 1,669   Balance sheet change%   10.8% -15.9% 42.1% 30.0% -10.5% 6.1% -61.6% 0.0%   Added value   512.1 477.4 764.2 1,443.0 -618.7 475.5 0.0 0.0   Added value %   34.0% 30.0% 7.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -100 -95 -63 -132 -132 -132 -6 0   Net sales trend   1.0 2.0 3.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   34.0% 30.0% 7.1% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   30.7% 27.0% 6.3% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   30.7% 27.0% 33.4% 38.6% -34.5% 12.1% 0.0% 0.0%   Net Earnings %   19.7% 19.7% 4.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   23.0% 22.7% 5.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   25.9% 25.3% 6.3% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.5% 15.9% 22.6% 34.7% -15.7% 10.0% 0.0% 0.0%   ROI %   21.9% 19.4% 32.2% 56.7% -24.4% 14.2% 0.0% 0.0%   ROE %   37.4% 32.5% 39.9% 56.7% -40.6% 18.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   28.5% 44.1% 43.0% 47.0% 34.8% 39.6% 100.0% 100.0%   Relative indebtedness %   135.2% 83.3% 18.2% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   134.4% 79.3% 11.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   281.2% 177.1% -22.9% 3.0% -209.0% 286.6% 0.0% 0.0%   Gearing %   172.9% 83.0% 38.7% 28.1% 93.7% 82.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.8% 2.3% 0.8% 6.0% 9.1% 9.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.5 0.5 0.3 0.2 0.0 0.0   Current Ratio   1.3 1.6 1.6 1.8 1.5 1.6 0.0 0.0   Cash and cash equivalent   12.3 62.3 761.2 562.0 43.8 58.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   22.0 13.7 4.7 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   172.4% 136.9% 29.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   561.0 853.5 1,241.3 1,936.9 1,234.8 1,592.3 0.0 0.0   Net working capital %   37.2% 53.7% 11.6% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 240 -88 59 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 240 -88 59 0 0   EBIT / employee   0 0 0 229 -98 51 0 0   Net earnings / employee   0 0 0 173 -104 36 0 0